Marinus Pharmaceuticals (MRNS) PT Lowered to $22 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Marinus Pharmaceuticals (MRNS) PT Lowered to $12 at Oppenheimer
November 9, 2022 7:59 AM ESTOppenheimer analyst Jay Olson lowered the price target on Marinus Pharmaceuticals (NASDAQ: MRNS) to $12.00 (from $23.00) while maintaining a Outperform rating.... More
Marinus Pharmaceuticals (MRNS) PT Lowered to $27 at H.C. Wainwright
November 9, 2022 7:15 AM ESTH.C. Wainwright analyst Douglas Tsao lowered the price target on Marinus Pharmaceuticals (NASDAQ: MRNS) to $27.00 (from $38.00) while maintaining a Buy rating.... More
Marinus Pharma (MRNS) Prices 10.53M Share Offering at $4.75/sh
November 8, 2022 5:40 AM ESTMarinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the pricing of its underwritten public offering of 10,526,316 shares of its common stock at a public offering price of $4.75 per share, and, to certain investors in lieu of common stock, pre-funded warrants to purchase 2,105,264 shares of common stock at a price of $4.749 per pre-funded warrant, for gross proceeds of approximately $60 million, before deducting underwriting discounts and commissions and offering expenses payable by Marinus. The purchase price per share of each pre-funded warrant... More
Marinus Pharma (MRNS) Announces Proposed Public Offering
November 7, 2022 4:23 PM ESTMarinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it has commenced an underwritten public offering of its securities. All of the securities to be sold in the offering are being offered by Marinus. In addition, Marinus... More
